Replies to post #286 on Axsome Therapeutics Inc (AXSM)

[smallbio]

This is the exact line in TDAmeritrade:

July 11, 2019
7:51 am ET
*Axsome Therapeutics Says Is Enrolling Two Open-Label Studied To Build Safety Databases Of Patients To Support The Filing Of A New Drug Application For AXS-05 In The Treatment Of Major Depressive Disorder Amd ASX-05 In MIgraine
Benzinga"

So looks like they quote Benzinga as the source.